Actavis Infringed Orexo's Zubsolv Patent, Del. Judge Rules
A Delaware federal judge has ruled that drugmaker Actavis Elizabeth LLC infringed an Orexo AB patent with its planned generic version of opioid addiction treatment Zubsolv, a ruling Orexo said will...To view the full article, register now.
Already a subscriber? Click here to view full article